Johnson & Johnson Could Have 100 Million COVID-19 Vaccines By April, Board Member McClellan Says By: TalkMarkets January 22, 2021 at 08:57 AM EST Johnson & Johnson is on track to analyze data from its late-stage single-dose COVID-19 vaccine trial. Read More >> Related Stocks: Johnson & Johnson